Therefore, we propose that defective histone acetylation-mediated downregulation of RALDH2 may contribute to aberrant moyamoya vessel formation by reducing RA synthesis and subsequently activating the Wnt-β-catenin/SOX17 signaling pathway in MMD. This evidence concerns the gene ALDH1A2 and multiminicore myopathy.